GlassScriptPhysician profile
Steven H Schneider
NPI 1063421659
$4,948.28
in general payments reported to CMS, 2019-2025
21 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $808 · 2021: $134 · 2022: $3,115 · 2023: $131 · 2024: $148 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,019.58 | 2021-2022 | |
| Covidien LP | $550.00 | 2020 | |
| Abbvie INC. | $319.62 | 2019-2020 | |
| Astellas Pharma US INC | $312.95 | 2019-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $183.53 | 2019-2025 | |
| Pfizer INC. | $63.56 | 2020-2023 | |
| Boston Scientific Corporation | $56.57 | 2019-2025 | Bulkamid |
| Sumitomo Pharma America, INC. | $52.97 | 2024 | Gemtesa |
| Sage Therapeutics, LLC | $47.98 | 2025 | Zurzuvae |
| Medtronic, INC. | $41.55 | 2022-2025 | Truclear |
| Caldera Medical, INC | $38.16 | 2022 | |
| Coopersurgical, INC. | $37.84 | 2024 | Paragard T 380a |
| Organon LLC | $36.70 | 2021-2022 | |
| Daiichi Sankyo INC. | $31.51 | 2019 | |
| Merck Sharp & Dohme LLC | $25.85 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $24.93 | 2021 | |
| Urovant Sciences INC | $24.35 | 2021 | |
| Amag Pharmaceuticals, INC. | $23.82 | 2019 | |
| Smith+Nephew, INC. | $21.58 | 2020 | |
| Supernus Pharmaceuticals, INC. | $20.44 | 2025 | Qelbree |
| Avion Pharmaceuticals | $14.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.